[RE]MEDs
AI-driven medicinal research
- B2B
- AI-native
About [RE]MEDs
[RE]MEDs utilizes AI technology for in-silico studies of medicinal effects, focusing on autoimmune disorders, while upholding ethics in pharmaceutical research
Key facts
- Industry
- Biotechnology
- Company size
- 1–10 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2020
- Revenue
- $3.1M – $24.1MTamtam estimate
- Website
- re-meds.com
- linkedin.com/company/re-meds
[RE]MEDs at a glance
[RE]MEDs is a B2B company in the Biotechnology industry, headquartered in Paris, Île-de-France, France.
[RE]MEDs was founded in 2020.
[RE]MEDs has 1–10 employees.
[RE]MEDs's revenue is $3.1M – $24.1M (Tamtam estimate).
Selling to companies like [RE]MEDs?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies